# Stem Cells in Myocardial Infarction

> **NCT00135928** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 78 (—)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Granulocyte Colony Stimulating Factor G-CSF (Neupogen®)

## Key facts

- **NCT ID:** NCT00135928
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 78 (—)
- **Last updated:** 2011-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00135928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00135928, "Stem Cells in Myocardial Infarction". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00135928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*